Kevin J. Kenny - 08 Jan 2024 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Reporting relationship: President of Global Spine
Issuer ticker: OFIX
Reported as of: 08 Jan 2024
Net transaction value: -$20,081
SEC form: 4
Accepted by SEC: 10 Jan 2024, 16:55:15 UTC
Prior SEC filing: 09 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Kimberley Elting, attorney-in-fact

Filing notes and source

Key filing fact

Kevin J. Kenny filed Form 4 for Orthofix Medical Inc. (OFIX) on 10 Jan 2024.

Key facts

This page summarizes Kevin J. Kenny's Form 4 filing for Orthofix Medical Inc. (OFIX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jan 2024, 16:55.

Change

Previous filing in this sequence was filed on 09 Jan 2024.
Current net transaction value: -$20,081.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OFIX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +5,959
Change %: +4.2%
Price: $0.000000
Shares after: 147,321
Date: 08 Jan 2024
Ownership: Direct
Footnotes: F1

OFIX transaction

Common Stock

Tax liability

Transaction value: -$20,081
Shares: -1,511
Change %: -1%
Price: $13.29
Shares after: 145,810
Date: 08 Jan 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OFIX transaction Derivative

Performance Share Units

Options Exercise

Transaction value: $0
Shares: -5,959
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 08 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,959
Exercise price: $0.000000
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Kevin J. Kenny is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

On April 4, 2023, the reporting person was granted 5,959 performance-based restricted stock units (PSUs). Such PSUs vested and converted to common stock on a one-for-one basis on January 8, 2024.

Footnote F2

Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The synergy target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).